10 Best Get Rich Quick Stocks to Buy Now

Page 9 of 9

1. Aptevo Therapeutics Inc. (NASDAQ:APVO)

Upside potential as of July 8, 2025: 13,451.61%

Beta (5Y Monthly): 5.73

As per the announcement last Tuesday, Aptevo Therapeutics Inc. (NASDAQ:APVO) has regained compliance with the Nasdaq Listing Rule 5550(b)(1), which requires listed companies to sustain at least $2.5 million in stockholders’ equity.

The company received a green signal from the Nasdaq’s Listing Qualifications Staff after previously disclosing that it was not in compliance for the quarter ended March 31, 2025. The approval was gained when Aptevo Therapeutics Inc. (NASDAQ:APVO) raised approximately $15.9 million in gross proceeds through additional equity capital during the recent quarter.

With this boost, Aptevo Therapeutics Inc. (NASDAQ:APVO) believes that it has achieved the $2.5 million mark in stockholders’ equity, meeting the listing prerequisites for The Nasdaq Stock Market LLC. Recently, the company announced the addition of preclinical candidate APVO455 to its core offerings, which include CD3-directed candidates built on the CRIS-7-derived CD3 binding domain approach. With a vision to address hematologic and solid tumors, this micro-cap company is in the right direction to outperform analysts’ expectations.

Aptevo Therapeutics Inc. (NASDAQ:APVO) is a Washington-based clinical-stage research and development biotechnology company that discovers and develops immunotherapeutic solutions targeting various cancers in the United States. Founded in 2016, the company utilizes ADAPTIR and ADAPTIR-FLEX platforms to advance its lead candidates.

While we acknowledge the potential of APVO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than APVO and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9